Former senior executive at Cano Health Inc
- Value-based PCP (primary care provider) market overview, highlighting Cano Health's (NYSE: CANO) relative differentiation
- Evaluation of Cano’s unique approach to patient engagement and localised healthcare
- Land-and-expand strategy, including key markets of interest
- Cano’s possible sale to healthcare giants such Humana (NYSE: HUM), UnitedHealth Group (NYSE: UNH) or CVS (NYSE: CVS), including relative acquisitive rationales
- 2023 outlook, management overview and strategic assessments
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.